Stocks and InvestingStocks and Investing
Tue, April 17, 2018
Mon, April 16, 2018
Fri, April 13, 2018
Thu, April 12, 2018
Wed, April 11, 2018
Tue, April 10, 2018
Mon, April 9, 2018
Fri, April 6, 2018
Thu, April 5, 2018

Geoff Meacham Maintained (ABBV) at Hold with Decreased Target to $102 on, Apr 5th, 2018


Published on 2024-10-26 04:17:46 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of Barclays, Maintained "AbbVie Inc." (ABBV) at Hold with Decreased Target from $120 to $102 on, Apr 5th, 2018.

Geoff has made no other calls on ABBV in the last 4 months.



There are 3 other peers that have a rating on ABBV. Out of the 3 peers that are also analyzing ABBV, 1 agrees with Geoff's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoffrey Porges of "Leerink Swann" Downgraded from Buy to Hold on, Monday, January 29th, 2018


These are the ratings of the 2 analyists that currently disagree with Geoff


  • Alex Arfaei of "BMO Capital" Maintained at Sell with Decreased Target to $80 on, Friday, March 23rd, 2018
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $145 on, Friday, February 2nd, 2018